Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, and Melissa...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.
News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European...
Ten out of the top 25 videos in 2019 are from hospital site visits DAIC conducted and shot more than 10 video interviews and recorded cath lab procedures at each center. Two of the videos here are walk throughs of cath labs, showing how Henry Ford Hospital and the University of Colorado set up their main hybrid rooms for structural heart procedures. This photo is from a MitraClip procedure during the University of Colorado visit last December.
Feature | December 30, 2019 | Dave Fornell, Editor
Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These...
News | Radial Access | December 30, 2019
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of...
News | Cardiovascular Business | December 30, 2019
December 30, 2019 — Most patients do not understand or recall information given to them before heart procedures. For...
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
Feature | Antiplatelet and Anticoagulation Therapies | December 27, 2019
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics...
The high cost of EP mapping and ablation catheters consumes about 60 percent of CMS reimbursement for atrial fibrillation catheter ablation procedures. This has led some hospitals to start reprocessing the catheters to cut costs. Photo by Dave Fornell.
Blog | Cardiovascular Business | December 23, 2019
With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important...
Videos | RSNA | December 18, 2019
DAIC Editor Dave Fornell and Imaging Technology News (ITN) Consulting Editor Greg Freiherr offer a post-game report...
News | Cath Lab | December 18, 2019
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S....
The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.
Feature | December 17, 2019
December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...
Feature | Pharmaceuticals | December 16, 2019 | Dave Fornell, Editor
December 16, 2019 — The U.S. Food and Drug Administration (FDA), on Dec. 13, approved the use of Vascepa (icosapent...
News | Virtual and Augmented Reality | November 27, 2019
November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and...
A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.
Feature | Heart Valve Technology | November 27, 2019 | Saipriya Iyer
The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to...
A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.
News | Heart Valve Technology | November 26, 2019 | Dave Fornell, Editor
November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a...
